What STD Pharmaceutical does

STD Pharmaceutical is a UK-based, privately held specialty medical device manufacturer, founded in 1967 and headquartered in Hereford, England. The company designs and produces sclerotherapy products and iontophoresis machines, positioning both product lines as minimally invasive, non-surgical treatment alternatives for clinical use cases such as venous disorders and hyperhidrosis. With 101-250 employees, it operates at small-to-mid scale within the broader medical devices sector.

The firm's core technology footprint centers on two adjacent device categories: injectable sclerotherapy solutions, used to treat varicose veins and related venous conditions via in-situ vessel sclerosing, and iontophoresis systems, which use controlled electrical current to drive topically applied medication transdermally. These are physical medical devices paired with consumable pharmaceutical components, produced under regulated medical-device manufacturing conditions. The combination of a 58-year continuous operating history and a narrow, clinically entrenched product niche suggests an established specialty manufacturer rather than a venture-stage growth company.

Revenue mechanics, distribution channels, customer mix, and pricing model were not disclosed in the available source material; the company's website and most structured data fields returned empty or placeholder values, limiting visibility into commercial operations. Based on its private status, Hereford base, and sub-250 headcount, STD Pharmaceutical appears to function as a focused B2B supplier to specialist clinicians, vein clinics, dermatology practices, and outpatient hospital departments, likely augmented by distribution into selected international markets typical of UK-originated medical device exporters.

Name

STD Pharmaceutical

Website

https://stdpharm.co.uk

Company type

Private

Founded year

1967

Headcount range

101–250 employees

Short description

STD Pharmaceutical is a UK-based, privately held specialty medical device manufacturer founded in 1967 and headquartered in Hereford, designing sclerotherapy products and iontophoresis machines as non-surgical treatment alternatives for clinical specialists and healthcare providers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Surgical and Medical Instrument Manufacturing (339112)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG)

akta.pro secondary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Sclerotherapy products
• Iontophoresis machines
• Varicose vein treatment
• Pharmaceutical manufacturing
• Medical devices

Headquarters

HQ city

Hereford

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

STD Pharmaceutical is a manufacturing company that designs and produces sclerotherapy products and iontophoresis machines intended to serve as non-surgical alternatives for the treatment of vascular and related conditions. Its offering combines pharmaceutical sclerosing agents with medical-device hardware (iontophoresis machines) for clinicians seeking surgery-free treatment options.

Differentiator

Problem solved

Functional benefit

Products and services

• Sclerotherapy products

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Kreussler Pharma: German specialty pharmaceutical company that manufactures polidocanol-based sclerotherapy products (e.g., Asclera). Direct competitor in the sclerosing agent category STD Pharmaceutical serves.
• Sinclair Pharma: UK-based specialty aesthetics pharmaceutical company with a portfolio of injectable and topical products. Comparable as a similarly sized UK/EU specialty pharma operator targeting aesthetic and dermatology channels.
• Dermadry: Direct-to-consumer iontophoresis device manufacturer for the treatment of hyperhidrosis. Closely comparable as a focused iontophoresis hardware competitor to STD Pharmaceutical's device line.
• Hidrex: German manufacturer of iontophoresis devices primarily for hyperhidrosis. Direct peer in the iontophoresis machine category where STD Pharmaceutical competes.
• R.A. Fischer & Co. US-based manufacturer of iontophoresis delivery systems for clinical and sweat-testing applications. Comparable as a focused iontophoresis device maker in the same clinical category.

Broad incumbents

• Boston Scientific (BTG/Varithena): Acquired BTG, which commercialized Varithena (polidocanol foam) for varicose vein treatment. Large incumbent competing with STD Pharmaceutical's sclerotherapy franchise via a foam-based formulation.
• AngioDynamics: Medical device company with a vascular disorders portfolio, including sclerotherapy and venous ablation products. Competes with STD Pharmaceutical across the non-surgical vein treatment workflow.
• Galderma: Global dermatology and aesthetics pharmaceutical company with a presence in injectable aesthetics. Adjacent competitor in aesthetics-driven vein and skin treatment categories where STD Pharmaceutical operates.
• Merz Aesthetics: Global aesthetics company with injectable and device offerings that compete in adjacent dermatology and vascular aesthetic treatment channels where STD Pharmaceutical's sclerotherapy and iontophoresis products are used.
• BTG (Boston Scientific): Originally British Technology Group, now part of Boston Scientific, with a strong interventional medicine and varicose vein treatment portfolio. Historical direct competitor in the sclerotherapy and vein care market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STD Pharmaceutical